Clinical Trial Update: Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating thyroid hormone replacement with levothyroxine (thyroxin) for subclinical hypothyroidism and its effects on the apnea-hypopnea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Obstructive Sleep Apnea
• Subclinical Hypothyroidism

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: King Saud University | Conditions: Dyslipidemia | Phase 3 | Status: UNKNOWN